Companies: 10,795·Total market cap: $144.5T
West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc.

WSTNYSEHealthcare● Active
$316.28
+$1.78(+0.56%)
Market Cap$22.3B
P/E Ratio
52W High$330.88
52W Low$206.8

West Pharmaceutical Services, Inc. (WST) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · WST · as of Sep 30, 2025

Ownership Breakdown

Institutions 97.94%
Insiders 0.64%
Public 1.42%

775

Institutional Holders

▲ 25 vs Q2

$18.06B

Total Inst. Value

▲ $2.78B vs Q2

70.65M

Shares Outstanding

freeFloat 99.36%

69.19M

13F Shares Held

▼ 859,239 vs Q2

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

Top Institutional Holders

WST largest shareholders · institutional ownership

Q3 2025 · SEC 13F

Showing top 10 holders

HolderShares% OwnedWeightValueReportedChange

VANGUARD GROUP INC

fabricated rubber products, nec

9.70M13.42%

13.42%

$2.55TNov 7, 2025 388.1K

BLACKROCK, INC.

fabricated rubber products, nec

6.46M8.93%

8.93%

$1.69TNov 12, 2025 149.1K

STATE STREET CORP

fabricated rubber products, nec

3.21M4.44%

4.44%

$841.53BNov 14, 2025 64.0K

BANK OF NEW YORK MELLON CORP

fabricated rubber products, nec

2.90M4.02%

4.02%

$761.99BNov 3, 2025 301.7K

ARTISAN PARTNERS LIMITED PARTNERSHIP

fabricated rubber products, nec

2.77M3.83%

3.83%

$726.90BNov 12, 2025 503.6K

BROWN ADVISORY INC

fabricated rubber products, nec

2.50M3.46%

3.46%

$655.33BNov 14, 2025 523.2K

GEODE CAPITAL MANAGEMENT, LLC

fabricated rubber products, nec

1.86M2.57%

2.57%

$485.20BNov 12, 2025 24.1K

MORGAN STANLEY

fabricated rubber products, nec

1.48M2.05%

2.05%

$387.89BMay 27, 2026 6.5K

VAN ECK ASSOCIATES CORP

fabricated rubber products, nec

1.42M1.97%

1.97%

$373.79BNov 13, 2025 61.3K

APG ASSET MANAGEMENT N.V.

fabricated rubber products, nec

1.41M1.96%

1.96%

$315.62BNov 12, 2025 245.0K

Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).

Institutional Activity

Q3 2025 vs prior quarter

Q3 2025

Net institutional sentimentBearish — more selling than buying

19

Increased

+3.30M shares

2

New Positions

first time holders

26

Decreased

−2.80M shares

0

Sold Out

fully exited

Net shares change (top 50)

+502.5K

+3.30M / −2.80M

Net new holders

-5

2 new / 0 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

WST insider trading · insider activity

Source: SEC Form 4

Buy 0%Active transactions only100% Sell

Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.

0

Buy transactions

0

Sell transactions

0.00

Buy/Sell ratio

$0M

Total disposed

Recent Insider Transactions

Showing 10 most recent · Common Stock only

Name · RoleDateTypeSharesPriceValueAfter Trans.Filing

Campbell Shane Alden

SVP, Proprietary Segment

May 12, 2026Tax Withhold134.927$312.07$42.1K612.796Form 4 ↗

Campbell Shane Alden

SVP, Proprietary Segment

May 12, 2026Tax Withhold84.329$312.07$26.3K274.13Form 4 ↗

Pucci Paolo

director

May 4, 2026Award79111.9KForm 4 ↗

Michels Douglas A

director

May 4, 2026Award79146.5KForm 4 ↗

Lockhart Stephen H

director

May 4, 2026Award7913.5KForm 4 ↗

LAI GOLDMAN MYLA

director

May 4, 2026Award79120.4KForm 4 ↗

Keller Deborah L

director

May 4, 2026Award79111.6KForm 4 ↗

Joseph Molly

director

May 4, 2026Award7914.4KForm 4 ↗

HAUGEN JANET BRUTSCHEA

director

May 4, 2026Award7912.4KForm 4 ↗

FRIEL ROBERT F

director

May 4, 2026Award7915.5KForm 4 ↗

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

West Pharmaceutical Services, Inc. (WST) is primarily owned by institutional investors, who hold approximately 97.9% of total shares outstanding. Company insiders own approximately 0.64%, while retail and public investors account for the remaining 1.42%.

The largest institutional shareholder of West Pharmaceutical Services, Inc. is VANGUARD GROUP INC, holding approximately 9.70 million shares — equal to 13.42% of outstanding shares — as of September 30, 2025.

A total of 775 institutional investors currently hold WST stock, with a combined institutional value of approximately $18.06 billion as of the most recent 13F filing period.

Frequently asked questions

WST ownership

West Pharmaceutical Services, Inc. (WST) is primarily owned by institutional investors, who hold approximately 97.9% of shares. The largest shareholder is VANGUARD GROUP INC with a 13.42% stake. Company insiders hold 0.64%. Data sourced from SEC Form 13F as of September 30, 2025.

who owns WST stockWST ownership structureSEC Form 13F institutional holdingsWST float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of September 30, 2025